Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview:

The global interventional cardiology devices market size reached US$ 21.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.

Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized. These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.

Interventional Cardiology Devices Market Trends:
The increasing prevalence of diabetes, hypertension and cardiovascular disorders, such as coronary artery disease (CAD, is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Interventional cardiology and embolic protection devices are widely used to capture embolic debris to ensure continuous blood flow and preventing blockages. Additionally, the development of innovative bioabsorbable and drug-eluting stents, pacemakers and drug-coated mesh tubes is acting as another growth-inducing factor. In line with this, the increasing utilization of advanced imaging solutions, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT) for early diagnosis and timely treatment of cardiovascular ailments, is also contributing to the growth of the market. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global interventional cardiology devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and end user.

Breakup by Product:

Stents
Drug Eluting Stents
Bare Metal Stents
Bio-Absorbable Stents
Interventional Catheters
IVUS Catheters
Guiding Catheters
Angiography Catheters
PTCA Guidewires
Balloon Inflation Device
PTCA Balloons
Cutting Balloons
Scoring Balloons
Drug Eluting Balloons
Normal Balloons

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Alvimedica, B. Braun Melsungen AG, Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.), BIOTRONIK Inc., Boston Scientific Corporation, Cook Group Incorporated, ENDOCOR GmbH, Koninklijke Philips N.V., Medinol Ltd., Medtronic plc and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global interventional cardiology devices market in 2022?
2. What is the expected growth rate of the global interventional cardiology devices market during 2023-2028?
3. What are the key factors driving the global interventional cardiology devices market?
4. What has been the impact of COVID-19 on the global interventional cardiology devices market?
5. What is the breakup of the global interventional cardiology devices market based on the product?
6. What is the breakup of the global interventional cardiology devices market based on the end user?
7. What are the key regions in the global interventional cardiology devices market?
8. Who are the key players/companies in the global interventional cardiology devices market?


1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3Executive Summary
4Introduction
4.1Overview
4.2Key Industry Trends
5Global Interventional Cardiology Devices Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6Market Breakup by Product
6.1Stents
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Drug Eluting Stents
6.1.2.2 Bare Metal Stents
6.1.2.3 Bio-Absorbable Stents
6.1.3 Market Forecast
6.2Interventional Catheters
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 IVUS Catheters
6.2.2.2 Guiding Catheters
6.2.2.3 Angiography Catheters
6.2.3 Market Forecast
6.3PTCA Guidewires
6.3.1 Market Trends
6.3.2 Market Forecast
6.4Balloon Inflation Device
6.4.1 Market Trends
6.4.2 Market Forecast
6.5PTCA Balloons
6.5.1 Market Trends
6.5.2 Key Segments
6.5.2.1 Cutting Balloons
6.5.2.2 Scoring Balloons
6.5.2.3 Drug Eluting Balloons
6.5.2.4 Normal Balloons
6.5.3 Market Forecast
7Market Breakup by End User
7.1Hospitals
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Ambulatory Surgical Centers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3Others
7.3.1 Market Trends
7.3.2 Market Forecast
8Market Breakup by Region
8.1North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9SWOT Analysis
9.1Overview
9.2Strengths
9.3Weaknesses
9.4Opportunities
9.5Threats
10Value Chain Analysis
11Porters Five Forces Analysis
11.1Overview
11.2Bargaining Power of Buyers
11.3Bargaining Power of Suppliers
11.4Degree of Competition
11.5Threat of New Entrants
11.6Threat of Substitutes
12Price Analysis
13Competitive Landscape
13.1Market Structure
13.2Key Players
13.3Profiles of Key Players
13.3.1Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2Alvimedica
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3B. Braun Melsungen AG
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 SWOT Analysis
13.3.4Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5BIOTRONIK Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6Boston Scientific Corporation
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7Cook Group Incorporated
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8ENDOCOR GmbH
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.9Koninklijke Philips N.V.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10Medinol Ltd.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.11Medtronic plc
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12Terumo Corporation
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings